Pfizer is the 13th drug manufacturer to impose conditions on 340B sales of prescription drugs involving contract pharmacies.

News Alert: Pfizer Becomes the 13th Drug Maker to Limit 340B Contract Pharmacies

UPDATE Friday, Jan. 28, 2022, 3:25 p.m.—The U.S. Health Resources and Services Administration (HRSA) said this afternoon it is reviewing Pfizer’s policy and will evaluate next steps as needed.

Pfizer today became the 13th drug manufacturer to impose conditions on 340B sales of prescription drugs involving contract pharmacies. Its changes take effect March 1 and affect hospitals only.

Pfizer today became the 13th drug manufacturer to impose conditions on 340B sales of prescription drugs involving contract pharmacy.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer